Zambon

Zambon is a chemical-pharmaceutical company with a rich history dating back to its foundation in 1906. The company prides itself on its commitment to innovating Cure & Care, with a mission to enhance patients’ lives. Operating in Europe, America, and Asia, Zambon has over 2,900 employees and manufacturing units in Italy, Switzerland, France, China, and Brazil, achieving impressive revenues of 899 million euros in 2023.

The pharmaceutical subsidiary, Zambon SpA, is expanding its role within the industry, focusing on diverse areas such as pain management, respiratory and urological diseases, and critical conditions like Parkinson’s Disease and Cystic Fibrosis. Additionally, the establishment of ZBiotech demonstrates their dedication to novel drug development and commercial viability through scouting, acquisition, licensing, and development of new molecules.

Zambon sets itself apart by managing the entire production chain through Zach-Zambon Chemicals, ensuring the production of high-quality products. Moreover, the company excels in providing modern health solutions and actively fosters innovation through Zcube-Zambon Research Venture, supporting the growth of pioneering projects and startups.

The diverse portfolio of Zambon also extends to ItaliAssistenza, a Home Care Company involved in patient support program design and the delivery of home care services. Headquartered in Milan, Italy, within the scientific campus OpenZone, Zambon fosters knowledge sharing with the goal of transforming research into enterprise.